FDA priority review seeks marstacimab label expansion to ≥6 years with inhibitors and ages 6–11 without inhibitors, addressing populations with limited efficacy from factor replacement and high unmet ...
PF'3944 is an ultra-long-acting fully biased GLP-1 receptor agonist (RA). It is being developed as a single agent weekly and as a monthly therapy, and in combination with various peptides including an ...
Integra Asset Solutions, in partnership with HGR24, is pleased to announce the upcoming online auction featuring a complete cleanroom injection molding operation from Enplas Life Tech, showcasing high ...
Eli Lilly plans injectable manufacturing site in Pennsylvania, creating 850 jobs and producing next-gen weight-loss medicines by 2031.
A tangle of emotions around aging—and the shame of doing something about it—bled into an eyebrow-raising covert operation.
Share on Pinterest The FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty Images In December 2025, the U.S. FDA approved an oral pill form of Wegovy for weight loss. Until ...
Removing part or all of the breast during breast cancer treatment is a potential outcome for some people. Reconstructive surgical procedures often involve prosthetic implants or transplanted tissue ...
Abstract: Fault injection is a widely used method of assessing the reliability of field-programmable gate array (FPGA) designs operating in harsh radiation environments. While typically conducted ...
ABSTRACT: Offshore heterogeneous conventional heavy oil reservoirs are mostly developed with irregular area injection-production well patterns. During the high water-cut stage, the problem of uneven ...
BETHLEHEM, Pa., Dec. 5, 2025 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, recently launched Piperacillin and Tazobactam, one of the most ...